Christina Mørk Hansen

Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity

Carina Danielsson, Ida Stenfeldt Mathiasen, Sharon Y. James et al. · Journal of Cellular Biochemistry · 1997 · 91 citations

Medicine, Molecular Biology, Oncology +13

1α,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cellsin vitro

Christina Mørk Hansen, Thomas Leth Frandsen, Nils Brünner et al. · Clinical & Experimental Metastasis · 1994 · 82 citations

Medicine, Cancer Biology, Oncology +14

Metabolism of the vitamin D analog EB 1089: Identification of in vivo and in vitro liver metabolites and their biological activities∗

Anne‐Marie Kissmeyer, Ernst Binderup, Lise Binderup et al. · Biochemical Pharmacology · 1997 · 57 citations

Medicine, Biochemistry, Pharmacology +16

Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells.

Åse Bratland, Karianne Risberg, Kristine B. Gützkow et al. · PubMed · 2000 · 53 citations

Medicine, Cancer Biology, Oncology +17

Molecular Evaluation of Vitamin D3 Receptor Agonists Designed for Topical Treatment of Skin Diseases11The authors declared not to have conflict of interest

Yvonne Bury, Dagmar Ruf, Carsten Carlberg et al. · Journal of Investigative Dermatology · 2001 · 40 citations · Full text

Medicine, Dermatology, Pharmacology +11